Cardiovascular disease remains the leading global killer. Still, too many late-stage cardiology trials stumble, not for lack of biology, but because episodic, clinic-bound measures miss what matters ...

The onslaught of endpoint attacks delivers more and more data — data that DevOps teams need to fine-tune existing products and invent new ones. Mining attack data to identify new threat patterns and ...

Less than half of the recent trials testing therapies for atherosclerotic cardiovascular disease (ASCVD) use the same endpoint, and many alter those endpoints after enrollment begins, according to a ...

Jeremy Wyatt, CEO, Ametris, explains how digital endpoints improve trial sensitivity, patient centricity, and efficiency through continuous real-world data, and why early regulatory collaboration is ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...